Durability of HBeAg Seroconversion After Treatment with Entecavir or Tenofovir in Chronic Hepatitis B Patients

被引：0
|
作者：
Fong, Tse-Ling [1 ,2 ]
Mena, Edward A. [3 ]
Yu, Andy S.
Quang-Quoc Phan
Han, Steven-Huy B. [4 ]
Tien, Andy [1 ]
Velasco, Andrew J. [1 ]
Leduc, Vinh-Huy [1 ]
Tong, Myron J. [3 ,4 ]
机构：
[1] St Vincents Med Ctr, Asian Pacific Liver Ctr, Los Angeles, CA USA
[2] Univ So Calif, Los Angeles, CA USA
[3] Huntington Med Res Inst, Pasadena, CA USA
[4] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1912
引用
收藏
页码：1121A / 1122A
页数：2
相关论文
共 50 条
  • [1] Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
    Tse-Ling Fong
    Andy Tien
    Kahee J. Jo
    Danny Chu
    Eddie Cheung
    Edward A. Mena
    Quang-Quoc Phan
    Andy S. Yu
    Wafa Mohammed
    Andrew Velasco
    Vinh-Huy LeDuc
    Nickolas Nguyen
    Steven-Bui Han
    Mimi Chang
    Ho S. Bae
    Yong-Won Cho
    Myron J. Tong
    Stewart L. Cooper
    Digestive Diseases and Sciences, 2015, 60 : 3465 - 3472
  • [2] Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
    Fong, Tse-Ling
    Tien, Andy
    Jo, Kahee J.
    Chu, Danny
    Cheung, Eddie
    Mena, Edward A.
    Quang-Quoc Phan
    Yu, Andy S.
    Mohammed, Wafa
    Velasco, Andrew
    Vinh-Huy LeDuc
    Nguyen, Nickolas
    Han, Steven-Bui
    Chang, Mimi
    Bae, Ho S.
    Cho, Yong-Won
    Tong, Myron J.
    Cooper, Stewart L.
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (11) : 3465 - 3472
  • [3] Sustained durability of HBeAG seroconversion in chronic hepatitis B patients after treatment with telbivudine
    Poynard, T.
    Hou, J. -L.
    Chutaputti, A.
    Manns, M.
    Naoumov, N.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S263 - S264
  • [4] Tenofovir is superior to entecavir in HBeAg positive treatment Naive chronic hepatitis B Patients
    Behera, Manas Kumar
    Pati, Girish Kumar
    Singh, Ayaskant
    Narayan, Jimmy
    Sahu, Manoj Kumar
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 474 - 474
  • [5] Durability of HBeAg seroconversion after adefovir dipivoxil treatment for chronic hepatitis B (CHB)
    Chang, TT
    Shiffman, M
    Tong, M
    Marcellin, P
    Liaw, YF
    Luengrojanakul, P
    Choy, GS
    James, C
    Ma, I
    Xiong, S
    Currie, G
    Brosgart, CL
    JOURNAL OF HEPATOLOGY, 2004, 40 : 126 - 126
  • [6] HBeAg seroconversion is lower in Asian versus non-Asian patients during treatment of chronic hepatitis B with tenofovir (TDF) or entecavir (ETV)
    Jo, Kahee
    Dodge, Jennifer L.
    Wadley, Adrian
    Wakil, Adil E.
    Baron, Jody L.
    Cooper, Stewart
    HEPATOLOGY, 2013, 58 : 669A - 670A
  • [7] Seroconversion of Hepatitis B Envelope Antigen (HBeAg) by Entecavir in a Child with Chronic Hepatitis B
    Hasosah, Mohammed Y.
    Ghandourah, Heba S.
    Alsahafi, Ashraf F.
    Sukkar, Ghassan A.
    Jacobson, Kevan
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2012, 18 (03): : 217 - 220
  • [8] Serum hepatitis B virus RNA is a predictor of HBeAg seroconversion and virological response with entecavir treatment in chronic hepatitis B patients
    Luo, Hao
    Zhang, Xia-Xia
    Cao, Li-Hua
    Tan, Ning
    Kang, Qian
    Xi, Hong-Li
    Yu, Min
    Xu, Xiao-Yuan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (06) : 719 - 728
  • [9] Serum hepatitis B virus RNA is a predictor of HBeAg seroconversion and virological response with entecavir treatment in chronic hepatitis B patients
    Hao Luo
    Xia-Xia Zhang
    Li-Hua Cao
    Ning Tan
    Qian Kang
    Hong-Li Xi
    Min Yu
    Xiao-Yuan Xu
    World Journal of Gastroenterology, 2019, (06) : 719 - 728
  • [10] Fatal fulminant hepatitis B after withdrawal of entecavir treatment in a patient with HBeAg seroconversion
    Sarikaya, M.
    Kocak, E.
    Koklu, S.
    Babali, A.
    Cakal, B.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2012, 75 (03): : 369 - 370
12345